Detection of pathogens by molecular methods provides a major advance in understanding the epidemiology of ARI in childhood, but the interpretation of results has some limitations, as indicated by Sly and Jones 2 and De Paulis et al. 1 We agree with those authors that there is no clear advantage in detecting viral coinfection to determine the appropriate treatment for the individual child. From an academic standpoint, however, the use of quantitative PCR techniques may allow a better assessment of the role of co-detection in the induction of immune response and respiratory symptoms. By allowing us to establish the viral load in nasopharyngeal aspirate samples, quantitative PCR techniques could, in theory, help identify cases with high acutephase viral replication of the agent responsible for symptoms or contribute to relativize the finding of trace amounts of DNA or RNA present in the sample. Future research on viral load, host genetic polymorphism and epigenetics may clarify the importance of different viral pathogens on disease severity in children with ARI.
Dear Editor,
The discussion about the role and impact of viruses on the respiratory health of children is not only important, but always stimulating and instigating.
New knowledge accumulates and changes concepts, as indicated in the editorial published in Jornal de Pediatria (Vol. 87, No. 4, 2011) by Sly and Jones, 1 which may or may not produce changes in clinical practice. It is worth remembering that both situations have consequences and should therefore be ideally based on the best available scientific evidence.
A letter to the Editor published in this issue of Jornal de Pediatria cites the study by Bezerra et al., 2 which is in some aspects different from our study. 3 While our results relate to viral investigation in hospitalized infants with infections of the lower respiratory tract, those of Bezerra et al. 2 refer to children under five years of age who received ambulatory care or were hospitalized due to upper and/or lower respiratory tract infections. Even so, the results are in agreement about the lack of influence of viral co-detection on the severity of infection. 2, 3 Several factors may contribute to the current controversy about the clinical relevance of viral co-detection in nasopharyngeal aspirates of children, including characteristics of the study population (age, clinical presentation, and others) and outcomes studied. Differentiating age groups is therefore important. Respiratory syncytial virus (RSV), for example, is associated with more severe symptoms in the first contact with the child, which usually occurs during the first year of life. In addition, RSV reinfections are frequent and associated with milder cases. Therefore, it may be assumed that finding RSV in respiratory secretions of children under one year or up to five years of age may represent different clinical situations that reflect different etiopathogenic mechanisms. The same is valid for the co-detection of RSV associated with other viruses.
The molecular methods for viral diagnosis increasingly enable the detection of agents with or without a pathogenic role, underscoring the clinical importance of questioning the role of each agent detected and of viral co-detection, as well as the importance of studies such as those mentioned above, which evaluate actual and usual clinical situations. Techniques that allow the quantification of viral load may contribute to the diagnosis of active infection in the presence of virus in the respiratory tract, but further studies involving relevant clinical situations, such as acute bronchiolitis or different types of asthma attacks, are still needed. No conflicts of interest declared concerning the publication of this letter.
